Cellular origins and etiological factors for squamous cell carcinoma and related cancer types of the bladder

Squamous cell carcinoma (SCC) of the bladder is a rare disease with poor prognosis and limited molecular profiling. Here we present a multi-layer, comparative investigation on bladder SCC and related cancers, namely pure urothelial carcinoma (UC), UC with squamous differentiation, and bladder adenocarcinoma. The mutational signatures of SCC, UC with squamous differentiation, and pure UC imply similar etiologies, with APOBEC-derived signatures found in around a third of samples. SCC and UC with squamous differentiation both highly express basal/squamous markers, different from the luminal profile in UC. We have also dissected the tumor microenvironment and cell type-specific expression in primary tumor and lymph node metastases of SCC at single-cell resolution, and SCC tumor cells also exhibit high expression of basal/squamous markers compared with the luminal feature in UC and adenocarcinoma. Similar mutational signatures present at different contributing fractions, combined with distinct transcriptomic features in various types of bladder cancer, provide an interesting perspective on etiological factors and suggest tumor initiation from potentially different urothelial cell types. The molecular landscape of SCC and related bladder cancers presented in this study improves our understanding of their etiologies and possible cellular origins, and may facilitate future prevention strategies and therapy development. © 2026 The Pathological Society of Great Britain and Ireland.

Authors

Institutions

Publication Details

Journal
The Journal of Pathology
Published
2026-04-14
DOI
https://doi.org/10.1002/path.70053
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cellular origins and etiological factors for squamous cell carcinoma and related cancer types of the bladder

Futong Tian, Bo Han, Jiaoxiang Wu, Shihao Bai et al.
The Journal of Pathology
Bladder and Urothelial Cancer Treatments
article

Cellular origins and etiological factors for squamous cell carcinoma and related cancer types of the bladder

Futong Tian, Bo Han, Jiaoxiang Wu, Shihao Bai, Nian Liu, Y Shi, Yanfang Chen, Jing Xiao, Guoliang Yang, Shengqian Ding, Q Liu, Mengyao Liu, Kun Tao, Sheng Cheng, Xianbin Su, Peipei Su, Zihan Yin, Shuaihu Yuan, Xuehui Duan, Die Wu, Qinghong Shen, Jingjuan Ren
article en

Abstract

Squamous cell carcinoma (SCC) of the bladder is a rare disease with poor prognosis and limited molecular profiling. Here we present a multi-layer, comparative investigation on bladder SCC and related cancers, namely pure urothelial carcinoma (UC), UC with squamous differentiation, and bladder adenocarcinoma. The mutational signatures of SCC, UC with squamous differentiation, and pure UC imply similar etiologies, with APOBEC-derived signatures found in around a third of samples. SCC and UC with squamous differentiation both highly express basal/squamous markers, different from the luminal profile in UC. We have also dissected the tumor microenvironment and cell type-specific expression in primary tumor and lymph node metastases of SCC at single-cell resolution, and SCC tumor cells also exhibit high expression of basal/squamous markers compared with the luminal feature in UC and adenocarcinoma. Similar mutational signatures present at different contributing fractions, combined with distinct transcriptomic features in various types of bladder cancer, provide an interesting perspective on etiological factors and suggest tumor initiation from potentially different urothelial cell types. The molecular landscape of SCC and related bladder cancers presented in this study improves our understanding of their etiologies and possible cellular origins, and may facilitate future prevention strategies and therapy development. © 2026 The Pathological Society of Great Britain and Ireland.

The Journal of Pathology
Tongji University (CN), Shanghai Jiao Tong University (CN), Shanghai University of Sport (CN), Renji Hospital (CN), Shanghai Innovative Research Center of Traditional Chinese Medicine (CN), People’s Hospital of Wenshan Prefecture (CN), Shanghai Institutes for Biological Sciences (CN), Tongren Hospital (CN), Shanghai Cancer Institute (CN), Tongji Hospital (CN), Cardiff University (GB)
Natural Science Foundation of Shanghai, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities
No poverty
Openalex Percentile: Top 18%
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.